Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
Aquatherapy for neurodegenerative disorders.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
Impairment of endothelial function in patients with multiple sclerosis.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
A Potent and Selective S1P(1) Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis.
Enigmatic GPCR Finds a Stimulating Drug.
Endoplasmic reticulum dysfunction in neurological disease.
Abnormal white matter properties in adolescent girls with anorexia nervosa.
Depression in multiple sclerosis: A long-term longitudinal study.
[Pharmacological treatment of spasticity in multiple sclerosis].
[Recent prognosis on etiology and pathophysiology of multiple sclerosis].
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Balo's Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Human endogenous retroviruses and the nervous system.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Myelin Basic Protein synthesis is regulated by small non-coding RNA 715.

Pages